chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: HEP
Symptoms: Visual impairment
Clinical narrative: Information has been received form a lawyer regarding a case in litigation which was reported in a literature article concerning a 47 year old female patient who on 20-MAY-1998 was vaccinated with a second dose of RECOMBIVAX HB (manufacturer unknown). Concomitant medication was not reported. The special master reported that there was a logical sequence of cause and effect in patient's having received the vaccination and then experiencing optic neuritis, the first symptom of her Devic's disease of variant of multiple sclerosis (MS). It was reported that two months after getting the second dose of the vaccine the patient noted retro-orbital pressure in her left eye followed by decreased visual function. On July 27, 1998, she noted a curtain over the superior visual field in her left eye. On 25-JAN-2009 she had an magnetic resonance imaging (MRI) scan of brain which was negative, although there was an abnormal signal in the upper cervical spinal cord. The physician diagnosed neurologic syndrome involving her optic nerves and spinal cord. The medical records during the patient's final hospitalization reflected that she died from demyelinating disease. It was reported that patient had a vaccine injury and her death was also vaccine related. The patient died in May (Year not reported) at age of 47. The reporter felt that Devic's disease and demyelinating disease were related to the therapy with RECOMBIVAX HB. No other information is available.
Sex: U
Vaccine: FLU3
Symptoms: Influenza, Influenza serology positive
Clinical narrative: Initial report received 09 March 2009 from a health care professional which involved a cluster of two patients. Two patients, also reported as employees (ages and dates of birth not reported), had received FLUZONE during early September 2008 (one patient received FLUZONE lot number U2761AA, second patient lot number not reported), and on an unspecified date during March 2009, both patients were diagnosed with the "flu, strain B". One patient was confirmed as type B by the Tenzyme test. At the time of the report, it was unclear which patient received FLUZONE lot number U2761AA, and which patient tested positive for Influenza Type B. The patient's recovery status was not reported. No additional information was provided at the time of the report. The reporter for this case is the same as for case numbers 2008-02996, 2008-03923, 2008-03924, 2008-03925, 2008-03926 and 2008-03927. Documents held by sender: None.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Angioedema, Pruritus, Urticaria
Clinical narrative: This case was received from a health care professional on 13 March 2009. A 17-year-old male patient, with a one-week history of upper respiratory infection, received an injection of MENACTRA on 11 March 2009 (lot number, site, and route of administration not reported). Shortly after vaccination, he developed angioedema, urticaria, and pruritis. He was treated with an antihistamine and DECADRON. At the time of the report, the events remained ongoing. The patient had no known allergies, and no medical conditions. Concomitant medication included FIORICET.
Age: 0.7
Sex: F
Vaccine: DTP
Symptoms: Ophthalmoplegia, VIth nerve paralysis, Vaccine positive rechallenge
Clinical narrative: Initial report received on 17 March 2009 from a literature collection. "An 8 month old female patient developed a left sixth nerve palsy 6 weeks after DPT Immunization (manufacturer and lot number not reported). The motility disturbance gradually resolved over the next 6 months. The following year the ophthalmoplegia recurred 3 months after DPT booster immunization, followed by resolution of the sixth nerve palsy over 2 months." The reporter of this case is the same as case number 2009-01116. List of Documents held by Sender: none.
Age: 71.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Epistaxis, Injection site pain, Injection site reaction, Oedema
Clinical narrative: Information has been received from an office manager concerning a patient who on an unspecified date, was vaccinated with PNEUMOVAX 23 (lot# 662599/1076X). It was unspecified if this was the first or second dose for the patient. Subsequently the patient developed "very severe" injection site reactions. The patient sought medical attention in the office. In follow-up, the office manager indicated that the patient was a 71 year old female with hypertension, overweight, hypothyroidism and no known allergies who on 10-FEB-2009 received a dose of PNEUMOVAX 23 (lot# 662599/1076X) into deltoid. On 10-FEB-2009, the patient experienced edema, epistaxis and pain at site of injection. The patient was treated with BENADRYL. The patient did not use steroid pack treatment. It took a week for the adverse events to clear. Subsequently, the patient recovered. It was reported the patient had no illness at time of vaccination and it was given at a new patient office visit. The reporter considered that the edema, epistaxis and pain at site of injection to be other important medical events. This is one of several reports from the same source. Additional information has been requested.
Age: 77.0
Sex: M
Vaccine: PPV
Symptoms: Activities of daily living impaired, Erythema, Injected limb mobility decreased, Nodule, Oedema peripheral
Clinical narrative: Information has been received from a doctor of pharmacy concerning a 77 year old male patient with arthritis of wrist, enlarged prostate (benign), hypertension, hyperlipidaemia and arthralgia of hand who in 1997 was vaccinated with first dose of PNEUMOVAX (Lot # not reported) in left deltoid. On 16-DEC-2008 he received second dose of PNEUMOVAX (Lot # 661899/0519X) in left deltoid. There was no concomitant medication. On 16-DEC-2008 within six hours after administration vaccine he developed pain in his left arm. The pain was debilitating with swelling, redness and knot. He was unable to use his left arm, could not dress himself and wore an arm sling. He had now developed pain on his right side as well. He had been seen by several doctors beginning on 19-DEC-2008. At that visit he was prescribed VICODIN, prednisone and advised to apply ice. On 19-DEC-2008, an x-ray was unremarkable. On 30-DEC-2008 he had a left shoulder cortisone injection. A magnetic resonance imaging (MRI), computed axial tomography (CT) scan and physical therapy had been prescribed but not started yet. At the time on the report on 17-MAR-2009 the patient was not recovered. Pain debilitating in his left arm with swelling, redness, knot and pain on his right side were considered to be disabling. Additional information has been requested.
Age: 77.0
Sex: M
Vaccine: PPV
Symptoms: Pain in extremity, X-ray normal
Clinical narrative: Information has been received from a doctor of pharmacy concerning a 77 year old male patient with arthritis of wrist, enlarged prostate (benign), hypertension, hyperlipidaemia and arthralgia of hand who in 1997 was vaccinated with first dose of PNEUMOVAX (Lot # not reported) in left deltoid. On 16-DEC-2008 he received second dose of PNEUMOVAX (Lot # 661899/0519X) in left deltoid. There was no concomitant medication. On 16-DEC-2008 within six hours after administration vaccine he developed pain in his left arm. The pain was debilitating with swelling, redness and knot. He was unable to use his left arm, could not dress himself and wore an arm sling. He had now developed pain on his right side as well. He had been seen by several doctors beginning on 19-DEC-2008. At that visit he was prescribed VICODIN, prednisone and advised to apply ice. On 19-DEC-2008, an x-ray was unremarkable. On 30-DEC-2008 he had a left shoulder cortisone injection. A magnetic resonance imaging (MRI), computed axial tomography (CT) scan and physical therapy had been prescribed but not started yet. At the time on the report on 17-MAR-2009 the patient was not recovered. Pain debilitating in his left arm with swelling, redness, knot and pain on his right side were considered to be disabling. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Abdominal pain upper, Activities of daily living impaired, Blood test, Malaise, Nausea
Clinical narrative: Information has been received from a consumer concerning her 15 year old daughter with no past medical history and no drug reactions or allergies who in August 2008, was vaccinated with the first dose of GARDASIL. In October 2008, the patient received the second dose of GARDASIL. There was no concomitant medication. The consumer reported that the patient developed a low grade fever and felt "sick" the day after receiving her second dose of GARDASIL. During October and November of 2008, the patient experienced intermittent "stomaches", nausea and vomiting. Starting December of 2008 until the time of this report, she had experienced persistent extreme stomach pains and vomiting. The patient had been examined by three gastroenteriologists who were not able to determine the cause of her symptoms. She had missed 60 days of school. Lab diagnostics studies included a stomach empty test, CAT scan and blood tests with no results available. At time of this report, the patient had not recovered. The patient sought medical attention by an office visit. Upon internal review, low grade fever, felt "sick", intermittent "stomaches", nausea, vomiting and persistent extreme stomach pains were considered to be disabling. Additional information has been requested.  3//25/09 MR received from parent which include several GI consults and diagnostic testing.  Per MR pt began having intermittent vomiting in Sept 2008.  Usually at night waking pt, accompanied by abdominal pain, H/A and associated with shaking/shivering/chills.  Occ nausea. 6-7 lb wt loss.  ROS (+) for fatigue and chest pain. PE WNL except for eczematous rash on hip, iliac crest and axilla. Some improvement with Reglan but now c/o dizziness. W/U essentially (-). No final DX. 2nd GI consult seen 1/9/09. PE (+) for tenderness to palpation of the epigastrium, RUQ and RLQ. Has missed 28 school days since Sept 08.   Labs and diagnostics:  Upper GI WNL. CBC WNL. Chem WNL. H. pylori (-). BX of esphagus and stomach WNL.  Some inflammation of lamina propria of duodenum. Upper GI (+) for small ring shadow of distal stomach with SB follow through WNL. Head CT WNL. US abd WNL. HIDA scan WNL. CT abd and pelvis WNL. Gastric emptying study WNL. X-ray abd (+) for increased stool. EGD WNL.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Pyrexia, Vomiting
Clinical narrative: Information has been received from a consumer concerning her 15 year old daughter with no past medical history and no drug reactions or allergies who in August 2008, was vaccinated with the first dose of GARDASIL. In October 2008, the patient received the second dose of GARDASIL. There was no concomitant medication. The consumer reported that the patient developed a low grade fever and felt "sick" the day after receiving her second dose of GARDASIL. During October and November of 2008, the patient experienced intermittent "stomaches", nausea and vomiting. Starting December of 2008 until the time of this report, she had experienced persistent extreme stomach pains and vomiting. The patient had been examined by three gastroenteriologists who were not able to determine the cause of her symptoms. She had missed 60 days of school. Lab diagnostics studies included a stomach empty test, CAT scan and blood tests with no results available. At time of this report, the patient had not recovered. The patient sought medical attention by an office visit. Upon internal review, low grade fever, felt "sick", intermittent "stomaches", nausea, vomiting and persistent extreme stomach pains were considered to be disabling. Additional information has been requested.  3//25/09 MR received from parent which include several GI consults and diagnostic testing.  Per MR pt began having intermittent vomiting in Sept 2008.  Usually at night waking pt, accompanied by abdominal pain, H/A and associated with shaking/shivering/chills.  Occ nausea. 6-7 lb wt loss.  ROS (+) for fatigue and chest pain. PE WNL except for eczematous rash on hip, iliac crest and axilla. Some improvement with Reglan but now c/o dizziness. W/U essentially (-). No final DX. 2nd GI consult seen 1/9/09. PE (+) for tenderness to palpation of the epigastrium, RUQ and RLQ. Has missed 28 school days since Sept 08.   Labs and diagnostics:  Upper GI WNL. CBC WNL. Chem WNL. H. pylori (-). BX of esphagus and stomach WNL.  Some inflammation of lamina propria of duodenum. Upper GI (+) for small ring shadow of distal stomach with SB follow through WNL. Head CT WNL. US abd WNL. HIDA scan WNL. CT abd and pelvis WNL. Gastric emptying study WNL. X-ray abd (+) for increased stool. EGD WNL.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Autism
Clinical narrative: Information has been received from a consumer concerning his daughter (a year old female) with no medical history or drug allergies who on 3-MAR-2006 was vaccinated with a dose of MMR II (lot # 649748/0301R). Secondary suspect vaccinations included: the third dose of hepatitis B virus (lot # 651854/0306R) and the first dose of VARIVAX (Merck) (lot # 64668/0625R). Concomitant therapy included the third dose of HIB. The patient had been formally diagnosed as Autistic shortly after receiving the vaccines. The patient sought medical attention by visiting the physician's office. Multiple tests had been performed. At the time of reporting the patient was not recovered. Upon internal review it was determined that "diagnosed as Autistic" was an other important medical event. There is no additional information.
Age: 43.0
Sex: M
Vaccine: MMR
Symptoms: Autism
Clinical narrative: Information has been received from a consumer concerning her son (a "43 year old" male) who "developed autism after receiving a dose of MMR II". Consumer also reported that "after the patient, who is her son received a dose of DTP he had a severe high fever and swelling." The consumer also reported that "after she received DTP she experienced swelling of the arm." Upon internal review, autism was determined to be an other important medical event. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Autism
Clinical narrative: Information has been received from a consumer concerning her daughter who became autistic after receiving a dose of MMR II. Upon internal review, autism was determined to be an other important medical event. No further information is available.
Age: 1.3
Sex: M
Vaccine: HIBV, MMR
Symptoms: Aphasia, Autism, Biopsy, Blood test, Cognitive disorder
Clinical narrative: Information has been received from a consumer concerning her 36 month old son with gastrointestinal issues who on 24-JUL-1998 was vaccinated with first dose of MMR II (Lot # not reported) and HIB (unspecified carrier). Then on 24-APR-2001 when he three years old he received the booster MMR II (Lot # not reported) as well DTaP and IPV. When the patient was 3 years the patient had two brain seizures and was sent to the emergency room where he had a magnetic resonance imaging (MRI), 23 hour electroencephalography (EEG) and they checked his blood levels for minerals (results not reported), but he was not admitted to the hospital. Then when he was 3 and a half years old he was having speech problems. The patient was going to speech therapy but he eventually lost all of his speech and was mute. The patient then was diagnosed with autism around 4 years old and at that time he started to experience gastrointestinal problems, where he had to get an endoscopy done and had a number of biopsy which the physician's found a strain of the measles. The patient still went to speech therapy and spoke in sentences when it only pertains to him, his gastrointestinal problems only flared up occasionally, he had cognitive impairment and sensory integration dysfunction and he could not have dairy products, bakery products and sugar. Upon internal review, brain seizures and autism were determined to be other important medical events. Additional information has been requested.
Age: 1.3
Sex: M
Vaccine: HIBV, MMR
Symptoms: Condition aggravated, Convulsion, DNA test for fragile X, Electroencephalogram, Endoscopy abnormal
Clinical narrative: Information has been received from a consumer concerning her 36 month old son with gastrointestinal issues who on 24-JUL-1998 was vaccinated with first dose of MMR II (Lot # not reported) and HIB (unspecified carrier). Then on 24-APR-2001 when he three years old he received the booster MMR II (Lot # not reported) as well DTaP and IPV. When the patient was 3 years the patient had two brain seizures and was sent to the emergency room where he had a magnetic resonance imaging (MRI), 23 hour electroencephalography (EEG) and they checked his blood levels for minerals (results not reported), but he was not admitted to the hospital. Then when he was 3 and a half years old he was having speech problems. The patient was going to speech therapy but he eventually lost all of his speech and was mute. The patient then was diagnosed with autism around 4 years old and at that time he started to experience gastrointestinal problems, where he had to get an endoscopy done and had a number of biopsy which the physician's found a strain of the measles. The patient still went to speech therapy and spoke in sentences when it only pertains to him, his gastrointestinal problems only flared up occasionally, he had cognitive impairment and sensory integration dysfunction and he could not have dairy products, bakery products and sugar. Upon internal review, brain seizures and autism were determined to be other important medical events. Additional information has been requested.
Age: 1.3
Sex: M
Vaccine: HIBV, MMR
Symptoms: Gastrointestinal disorder, Measles, Measles antibody positive, Nuclear magnetic resonance imaging, Sensory integrative dysfunction
Clinical narrative: Information has been received from a consumer concerning her 36 month old son with gastrointestinal issues who on 24-JUL-1998 was vaccinated with first dose of MMR II (Lot # not reported) and HIB (unspecified carrier). Then on 24-APR-2001 when he three years old he received the booster MMR II (Lot # not reported) as well DTaP and IPV. When the patient was 3 years the patient had two brain seizures and was sent to the emergency room where he had a magnetic resonance imaging (MRI), 23 hour electroencephalography (EEG) and they checked his blood levels for minerals (results not reported), but he was not admitted to the hospital. Then when he was 3 and a half years old he was having speech problems. The patient was going to speech therapy but he eventually lost all of his speech and was mute. The patient then was diagnosed with autism around 4 years old and at that time he started to experience gastrointestinal problems, where he had to get an endoscopy done and had a number of biopsy which the physician's found a strain of the measles. The patient still went to speech therapy and spoke in sentences when it only pertains to him, his gastrointestinal problems only flared up occasionally, he had cognitive impairment and sensory integration dysfunction and he could not have dairy products, bakery products and sugar. Upon internal review, brain seizures and autism were determined to be other important medical events. Additional information has been requested.
Age: 1.3
Sex: M
Vaccine: HIBV, MMR
Symptoms: Speech disorder
Clinical narrative: Information has been received from a consumer concerning her 36 month old son with gastrointestinal issues who on 24-JUL-1998 was vaccinated with first dose of MMR II (Lot # not reported) and HIB (unspecified carrier). Then on 24-APR-2001 when he three years old he received the booster MMR II (Lot # not reported) as well DTaP and IPV. When the patient was 3 years the patient had two brain seizures and was sent to the emergency room where he had a magnetic resonance imaging (MRI), 23 hour electroencephalography (EEG) and they checked his blood levels for minerals (results not reported), but he was not admitted to the hospital. Then when he was 3 and a half years old he was having speech problems. The patient was going to speech therapy but he eventually lost all of his speech and was mute. The patient then was diagnosed with autism around 4 years old and at that time he started to experience gastrointestinal problems, where he had to get an endoscopy done and had a number of biopsy which the physician's found a strain of the measles. The patient still went to speech therapy and spoke in sentences when it only pertains to him, his gastrointestinal problems only flared up occasionally, he had cognitive impairment and sensory integration dysfunction and he could not have dairy products, bakery products and sugar. Upon internal review, brain seizures and autism were determined to be other important medical events. Additional information has been requested.
Age: 9.0
Sex: F
Vaccine: MMR
Symptoms: Autism
Clinical narrative: Information has been received from a consumer concerning his 9 year old daughter, who on an unspecified date, was vaccinated with MMR II (Lot number was not available). There was no concomitant medication. The reporter stated that his daughter was diagnosed with autism after receiving the MMR II. Unspecified autism tests were performed with unreported results. Reporter did not provide physician's information. At the time of the report, the patient had not recovered. The patient sought medical attention and was seen by a physician. Upon internal review, autism was determined to be an other important medical event. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Autism, Eye movement disorder, Gait disturbance, Repetitive speech, Speech disorder
Clinical narrative: Information has been received from a consumer concerning a her 4 year old son with allergy to metals and a history of high fever in approximately in August, 2003 (required emergency room visit but was not admitted to the hospital); who on 10-FEB-2004 was vaccinated with MMR II (Lot # not available). Concomitant therapy included DTaP, poliovirus vaccine and PREVNAR and other 2 unspecified vaccines, all given approximately in March, 2003. The consumer reported that the day after receiving the MMR II, on 11-FEB-2004, the patient was seen with signs of autism (onset date reported by the same consumer as "somewhere in 2005"). Per mother, her son "had difficulties putting two words together like mama and one day he woke up and did not look at me directly but instead tilted his head towards the ceiling and then looked down and turned far left or right and he started to repeat words over and over again". The consumer also reported that the patient walked on tippy except the toe nails are down. An unspecified biological test was performed with unknown results. At the time of the report, the patient had not recovered. The patient sought medical attention and was seen by a physician. Upon internal review, autism was determined to be an other important medical event. Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: MMR
Symptoms: Autism, Childhood disintegrative disorder, Diet refusal, Incorrect route of drug administration
Clinical narrative: Information has been received from a consumer concerning her 8 year old grandson with no medical history who in 2001 was vaccinated with a 0.5 ml first dose of MMR II, intramuscularly. There was no concomitant medication. In 2001 after the patient received the MMR II the patient developed autism. According with the reporter "it was like a light switch", he stopped jabbering and eating. He would only drink juice from a green sippy cup. He has improved over the last year while following a strict organic diet. The patient sought unspecified medical attention. Upon internal review autism was determined to be an other important medical event. Additional information has been requested.
Age: 1.3
Sex: M
Vaccine: MMR
Symptoms: Autism
Clinical narrative: Information has been received from a consumer concerning her grandson, a now 10 year old male, with no known drug reaction/allergies and no pertinent medical history, who in approximately 1999, when he was 15 to 18 months old, was vaccinated MMR II, 0.5ml, subcutaneously. There was no concomitant medication. The reporter stated that in approximately 1999, right after the injection was given, the patient experienced developed autism. The consumer did not want to provide complete information of the adverse event. She did not want to have a follow up on this adverse event. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. Upon internal review, autism was determined to be an other important medical event. Additional information is not expected.
Sex: M
Vaccine: MMR
Symptoms: Autism
Clinical narrative: Information has been received from a consumer her son, with no known drug reactions/allergies and no pertinent medical history, who on unspecified dates was vaccinated with the first and second doses of MMR II, 0.5 ml. No lot number was provided. There was no concomitant medication. The patient's mother reported that within 4 months after receiving the vaccine, the patient became autistic. The consumer stated "he did however receive the second dose". She also stated that through early intervention patient has improved, however he still was autistic. At the time of the report, the patient was recovering. The patient sought unspecified medical attention. Upon internal review, autism was determined to be an other important medical event. No further information is available.
Age: 10.0
Sex: F
Vaccine: FLU3
Symptoms: Death, Influenza, Influenza serology positive
Clinical narrative: Possible vaccine failure. Child expired with Flu A cultured. 5/20/09-autopsy report received-COD-cardiopulmonary arrest. Due to: systemic infection with influenza type A/H1. Sudden onset of muscle and leg cramps on 2/14/09, URI symptoms last day or so including sore throat. Suddenly developed tachypnea fever and diaphoresis within 20n minutes of onset of leg cramps. In ED fever of 107, tachycardia and dyspnea, developed flutter then bradycardia. Intubated, v-tach, coded and expired.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Local reaction
Clinical narrative: 7x7 cm local swollen, red , warm on lateral left arm. No fever.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Pyrexia
Clinical narrative: 3 inch area of erythema, fever to 101.5 degrees F 24 hours after injection of ADACEL left arm.
Age: 63.0
Sex: M
Vaccine: FLU3, HEP
Symptoms: Rash
Clinical narrative: Vaccines given 2/23/09.  Patient monitored 30 minutes post vaccines.  No problems or complaints reported.  Patient returned for visit 2/26/09 & reported rash onset est. 20 hours post vaccinations.  No respiratory complaints.  Rash is resolving.  Pt has not yet contacted PCP.  He agrees to do so today 2/26/09.
Age: 14.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, VARCEL
Symptoms: Culture wound, Erythema, Herpes simplex serology, Rash vesicular
Clinical narrative: On 3/12/09 Pt presented here with vesicular like lesions to tip of nose and another vesicular like area with redness to left side of nose. Normal eye and facial exam. Cultures taken with rupture of one vesicle discussed with Opth to confirm that eye only needs TX if SX's develop. Tx: 1) Valtrex tab 1GM q 8hrs X 7 days 2) Zovirax Top Ointment 5% q 3h topically 7 days 3) Keflex 500mg QID 10 days.
Age: 1.1
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Injection site erythema, Injection site rash, Rash maculo-papular
Clinical narrative: Red maculopapules x 3 clustered on left upper anterior thigh at site of VCZ vaccine.
Age: 0.6
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Febrile convulsion
Clinical narrative: Febrile seizure seen at Hospital on 03-08-09. No activity since.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Basophil count decreased, Blood albumin normal, Blood alkaline phosphatase normal
Clinical narrative: Pt developed rash approx 10 days post SPV inoculation. Petechiae also noted. Pt also had a dental surgery the day following SPV inoculation and was treated with AMOXY, and MOTRIN and PERCOCET. Rash may have been drug eruption related to these meds.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood bilirubin normal, Blood calcium normal, Blood chloride normal, Blood creatinine normal, Blood glucose normal
Clinical narrative: Pt developed rash approx 10 days post SPV inoculation. Petechiae also noted. Pt also had a dental surgery the day following SPV inoculation and was treated with AMOXY, and MOTRIN and PERCOCET. Rash may have been drug eruption related to these meds.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood potassium normal, Blood sodium normal, Blood urea normal, Carbon dioxide normal, Eosinophil count decreased
Clinical narrative: Pt developed rash approx 10 days post SPV inoculation. Petechiae also noted. Pt also had a dental surgery the day following SPV inoculation and was treated with AMOXY, and MOTRIN and PERCOCET. Rash may have been drug eruption related to these meds.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Haematocrit normal, Haemoglobin normal, Lymphocyte count, Mean cell haemoglobin concentration, Mean cell haemoglobin normal
Clinical narrative: Pt developed rash approx 10 days post SPV inoculation. Petechiae also noted. Pt also had a dental surgery the day following SPV inoculation and was treated with AMOXY, and MOTRIN and PERCOCET. Rash may have been drug eruption related to these meds.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Mean cell volume, Mean platelet volume increased, Monocyte count, Neutrophil count, Petechiae
Clinical narrative: Pt developed rash approx 10 days post SPV inoculation. Petechiae also noted. Pt also had a dental surgery the day following SPV inoculation and was treated with AMOXY, and MOTRIN and PERCOCET. Rash may have been drug eruption related to these meds.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Platelet count normal, Protein total normal, Rash, Red blood cell count normal, Red blood cell sedimentation rate decreased
Clinical narrative: Pt developed rash approx 10 days post SPV inoculation. Petechiae also noted. Pt also had a dental surgery the day following SPV inoculation and was treated with AMOXY, and MOTRIN and PERCOCET. Rash may have been drug eruption related to these meds.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Red cell distribution width normal, Urine analysis normal, White blood cell count increased
Clinical narrative: Pt developed rash approx 10 days post SPV inoculation. Petechiae also noted. Pt also had a dental surgery the day following SPV inoculation and was treated with AMOXY, and MOTRIN and PERCOCET. Rash may have been drug eruption related to these meds.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Haematocrit normal, Haemoglobin normal, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal
Clinical narrative: Pt developed rash approx 10 days post SPV inoculation. Petechiae also noted. Pt also had a dental surgery the day following SPV inoculation and was treated with AMOXY, and MOTRIN and PERCOCET. Rash may have been drug eruption related to these meds.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Petechiae, Platelet count normal, Rash, Red blood cell count normal, Red cell distribution width normal
Clinical narrative: Pt developed rash approx 10 days post SPV inoculation. Petechiae also noted. Pt also had a dental surgery the day following SPV inoculation and was treated with AMOXY, and MOTRIN and PERCOCET. Rash may have been drug eruption related to these meds.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: White blood cell count increased
Clinical narrative: Pt developed rash approx 10 days post SPV inoculation. Petechiae also noted. Pt also had a dental surgery the day following SPV inoculation and was treated with AMOXY, and MOTRIN and PERCOCET. Rash may have been drug eruption related to these meds.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Left thigh red, hot and swollen x 6 days measured 10cm x 6cm. ZYRTEC given and started on 3/10.
Age: 51.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site induration, Injection site pain
Clinical narrative: Induration and tenderness at injection site when seen one week later.
Age: 14.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Wrong drug administered
Clinical narrative: On 12/17/08 patient presented as a new patient and I found she was under immunized needing one polio and two tetanus boosters. I elected to give her KINRIX followed in 6 months by ADACEL. I did no know then KINRIX was limited to <7.
Age: 14.0
Sex: F
Vaccine: HEPA, HPV4, TDAP
Symptoms: Head injury, Syncope
Clinical narrative: Patient fainted and hit her head, applied ice pack and examined by Dr. Waited in clinic for 1/2 hour after and was fine. Did have a bump on her forehead from fainting.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Zoster
Age: 10.0
Sex: M
Vaccine: TD, VARCEL
Symptoms: Erythema, Injection site swelling
Clinical narrative: Local erythema with superficial swelling 5x6 cm over vacc site apparently on the next day. Adv Motrin, OTC Benadryl, cold compress.
Age: 62.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Polymerase chain reaction, Rash papular
Clinical narrative: Pt developed papulovesicular lesions which developed into a rash along the T8 dermatome approximately Pt called back 2 days after ZOSTAVAX.
Age: 62.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Body temperature decreased, Herpes zoster, Pain, Pruritus, Rash papular
Clinical narrative: Pt developed papulovesicular lesions which developed into a rash along the T8 dermatome approximately Pt called back 2 days after ZOSTAVAX.
Age: 62.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Skin lesion, Varicella virus test positive
Clinical narrative: Pt developed papulovesicular lesions which developed into a rash along the T8 dermatome approximately Pt called back 2 days after ZOSTAVAX.
Age: 33.0
Sex: F
Vaccine: HEP
Symptoms: Antinuclear antibody, Arthralgia, Blood thyroid stimulating hormone, CSF culture, Full blood count
Clinical narrative: C/o fall with knee pain on 11-19-08 - Motrin, knee brace - C/o stickling knee with pain on 12-17-08; numbness in toes-INDOCIN with MRI (L) knee with P.T. - C/o "unable to walk on 2-21-09 when counseled about non compliance. - MRI on 1-29-09 (knee) moderate grade strain - MRI on 2-25-09 (cervical spine) disc herniation C5-6. Central disc bulge with questionable tiny annular tear at C6-7- (R) neural foramen narrowing at C5-6 - Spinal canal stenosis at C5-6 & C6 -7, 2-25-09 MRI. Disc space narrowing & disc desiccation at T12 -L1. No abnormal entrancement post contrast. No evidence thoracic spine disc herniation or posterior bulge. Enhancement of cauda equina and spinal nerve roots. Possible G-B syndrome vs arachnoiditis vs meningitis, 03-17-09 MRI.
Age: 33.0
Sex: F
Vaccine: HEP
Symptoms: Gait disturbance, Hypoaesthesia, Liver function test, Metabolic function test, Nuclear magnetic resonance imaging abnormal
Clinical narrative: C/o fall with knee pain on 11-19-08 - Motrin, knee brace - C/o stickling knee with pain on 12-17-08; numbness in toes-INDOCIN with MRI (L) knee with P.T. - C/o "unable to walk on 2-21-09 when counseled about non compliance. - MRI on 1-29-09 (knee) moderate grade strain - MRI on 2-25-09 (cervical spine) disc herniation C5-6. Central disc bulge with questionable tiny annular tear at C6-7- (R) neural foramen narrowing at C5-6 - Spinal canal stenosis at C5-6 & C6 -7, 2-25-09 MRI. Disc space narrowing & disc desiccation at T12 -L1. No abnormal entrancement post contrast. No evidence thoracic spine disc herniation or posterior bulge. Enhancement of cauda equina and spinal nerve roots. Possible G-B syndrome vs arachnoiditis vs meningitis, 03-17-09 MRI.
Age: 18.0
Sex: F
Vaccine: HEP, HPV4, IPV
Symptoms: Drug exposure during pregnancy, Fungal infection, Headache, Muscle spasms, Pain
Clinical narrative: Information has been received from a consumer, for GARDASIL, a Pregnancy Registry product, concerning her daughter in law, an 18 year old female with no drug allergy who on 02-SEP-2008 was vaccinated with the first dose of GARDASIL while few weeks pregnant.  Concomitant therapy included poliovirus vaccine (manufacturer unknown) and RECOMBIVAX HB.  The patient was now 24 weeks pregnant and was experiencing some cramping, headaches, occasional spasm in the rib cage area, yeast infections and general body aches.  She already had a yeast infection when getting GARDASIL and was prescribed and unspecified medication for it;  however the infections were coming back.  The patient performed pregnancy test and ultrasounds.  The first ultrasound came back normal.  The patient had a second ultrasound done.  At time of the report the patient was not recovered.  The patient sought medical attention.  Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HEP, HPV4, IPV
Symptoms: Ultrasound scan normal
Clinical narrative: Information has been received from a consumer, for GARDASIL, a Pregnancy Registry product, concerning her daughter in law, an 18 year old female with no drug allergy who on 02-SEP-2008 was vaccinated with the first dose of GARDASIL while few weeks pregnant.  Concomitant therapy included poliovirus vaccine (manufacturer unknown) and RECOMBIVAX HB.  The patient was now 24 weeks pregnant and was experiencing some cramping, headaches, occasional spasm in the rib cage area, yeast infections and general body aches.  She already had a yeast infection when getting GARDASIL and was prescribed and unspecified medication for it;  however the infections were coming back.  The patient performed pregnancy test and ultrasounds.  The first ultrasound came back normal.  The patient had a second ultrasound done.  At time of the report the patient was not recovered.  The patient sought medical attention.  Additional information has been requested.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness
Clinical narrative: Information has been received from a 20 year old female with no medical history and drug allergies who in February 2008 was vaccinated with her first does of GARDASIL. Concomitant therapy included birth control pill (unspecified which one). The patient was fine at first after vaccination but later she started feeling dizzy and light headed for the rest of the day. She was fine the next day and was now recovered. However, she did not receive the other two doses of GARDASIL. The patient did not seek medical attention. Additional information has been requested.
Age: 24.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Electrocardiogram normal, Pericardial disease
Clinical narrative: Unspecified disease of pericardium
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site mass, Injection site swelling, Injection site warmth
Clinical narrative: 1 inch red raised area at injection site hot to touch and lump felt under the area
Age: 23.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Electrocardiogram abnormal, Myocarditis, Troponin I increased
Clinical narrative: Non-specific myocarditis
Age: 22.0
Sex: M
Vaccine: MMR, SMALL, TYP, MMR, SMALL, TYP
Symptoms: Electrocardiogram, Nuclear magnetic resonance imaging, Pericarditis, Troponin I
Clinical narrative: Acute pericarditis, unspecified
Age: 26.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Electrocardiogram, Pericarditis, Troponin I
Clinical narrative: Acute pericarditis, unspecified; Unspecified disease of pericardium.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Chest pain, Dizziness, Echocardiogram, Postural orthostatic tachycardia syndrome, Supraventricular tachycardia
Clinical narrative: supraventricular tachycardia, dizziness, chest pain. Brought to emergency room by ambulance and admitted to a cardiac telemetry unit for 7 days. Numerous tests and procedures performed, ie, echo, EPS, tilt table...  4/28/09 Received hospital medical records of 1/28-2/4/2009. FINAL DX: supraventricular tachycardia; vasovagal syncope Records reveal patient experienced palpitations upon awakening similar to prior episodes but she was unable to break out of it with vagal maneuvers.  Also had chest pain, SOB, diaphoresis, dizziness & nausea.  Admitted to CCU for monitoring.  Had couple of pre-syncope episodes while hospitalized.  No episodes of SVT on monitor.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Tilt table test
Clinical narrative: supraventricular tachycardia, dizziness, chest pain. Brought to emergency room by ambulance and admitted to a cardiac telemetry unit for 7 days. Numerous tests and procedures performed, ie, echo, EPS, tilt table...  4/28/09 Received hospital medical records of 1/28-2/4/2009. FINAL DX: supraventricular tachycardia; vasovagal syncope Records reveal patient experienced palpitations upon awakening similar to prior episodes but she was unable to break out of it with vagal maneuvers.  Also had chest pain, SOB, diaphoresis, dizziness & nausea.  Admitted to CCU for monitoring.  Had couple of pre-syncope episodes while hospitalized.  No episodes of SVT on monitor.
Age: 5.0
Sex: F
Vaccine: DTAPHEPBIP, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site inflammation, Injection site oedema, Injection site pain, Injection site pruritus
Clinical narrative: Pediarix given IM to LD and MMR given  on 03/18/09.  Mom returned on 03/19/09 and child had edema at injection site that started 2 inches above injection site down to 1 inch above elbow. Site red, inflammed with blisters around injection site.  Child states arm hurts.  Encouraged cold pack to injection site, otc pain meds. Telephone call to mom on 03/20/09 and states that child much better but now complaining of itching to the injection site. No longer complaining of pain. Continues to apply cold packs to area throughout the day. Encouraged a otc anti itch cream or benydryl to help discomfort from itching.  Mom voiced understanding.  Telephone call to mom to check on status of child on 03-23-09 and mom states problems resolved and no evidence that shot had been administered to LD.  Informed mom that reaction to vaccine would be documented for future reference.
Age: 5.0
Sex: F
Vaccine: DTAPHEPBIP, HEPA, MMR, VARCEL
Symptoms: Injection site vesicles
Clinical narrative: Pediarix given IM to LD and MMR given  on 03/18/09.  Mom returned on 03/19/09 and child had edema at injection site that started 2 inches above injection site down to 1 inch above elbow. Site red, inflammed with blisters around injection site.  Child states arm hurts.  Encouraged cold pack to injection site, otc pain meds. Telephone call to mom on 03/20/09 and states that child much better but now complaining of itching to the injection site. No longer complaining of pain. Continues to apply cold packs to area throughout the day. Encouraged a otc anti itch cream or benydryl to help discomfort from itching.  Mom voiced understanding.  Telephone call to mom to check on status of child on 03-23-09 and mom states problems resolved and no evidence that shot had been administered to LD.  Informed mom that reaction to vaccine would be documented for future reference.
Age: 37.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Injection site erythema, Injection site pruritus, Rash generalised, Rash pruritic, Rash pustular
Clinical narrative: member presented for follow up after recieving his small pox vaccine and anthrax on the 8th. On the 17th he had erythema and itching at the site. On the 18th he returned with somilar sx. He developed an all over rash on the 20th in the evening that was extremely pruitic. He was seen in the med clinic on the 23rd and dx with non-viral pustulosis
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Paraesthesia, Pruritus, Rash
Clinical narrative: Patient received the zoster vaccine at the VA clinic 2/5/09.  At his f/u visit 3/3/09 he reported he'd developed a shingles rash approx 10 days after the vaccine.  An exam noted a rash on the right mid-back and on the anterior right chest at approximately the T3 dermatome - consistent with a shingles rash.  Patient reported mild pain (pins and needles type) and itching.
Age: 48.0
Sex: F
Vaccine: RAB
Symptoms: Abdominal discomfort, Arthralgia, Arthritis, Body temperature increased, Diarrhoea
Clinical narrative: Rabies vaccine was given on 3-6-09 @ 9:35 am.  On 3-16-09 @ 2 pm patient developed a mild headache.  Between 5:30 and 6 pm she developed general malaise, some little generalized aches.  Between 6 and 9 pm she developed joint aches, muscular aches, T 100 - 101 F, extreme nausea without vomiting and throughout the evening all the symptoms became worse.  After 9 pm she developed diarrhea, for which she took 2 OTC anti-diarrhea pills (? name) as directed for initial dose, without any relief.  She also experienced abdominal discomfort prior to and during diarrhea.  They offered no relief and she never took any more of this medication.  During the same night, her symptoms worsened throughout the evening, and could only sleep for 15 mins. at a time.  She experienced night sweats.  She took IBF 400 mg. PO @ 1 - 2 am on 3-19-09, also without relief, so did not take any further doses.  She then took Tylenol 1000  mg.  Q 4-6 hrs., but not more than 4 doses in 24 hrs. with some relief throughout the days that she had these symptoms.  On 3-18 PM or 3-19 PM, she began to take chewable pepto ismal for nausea, because it was so severe.  She also drank juice and water throughout the days of these symptoms.  The fever left either 3-20-09 in the evening or 3-21-09 @ 2 - 3 am, and then she was able to sleep.  All of these symptoms continued, but she was feeling progressively better.  She did not feel well enough to return to work until 3-23-09, but reports that she is not feeling well.  She reports feeling lethargic and joint aches continuing.  She complains especially of cervical neck pain with limited ROM, and has made an appointment with her neurosurgeon, since she had surgery last year.  She also complains of her shoulders and hands bothering her, where she has arthritis.  She has not taken her Voltran in 1 week, because she was taking other medication.  She will be talking with her PMD later today.
Age: 48.0
Sex: F
Vaccine: RAB
Symptoms: Headache, Joint range of motion decreased, Lethargy, Malaise, Myalgia
Clinical narrative: Rabies vaccine was given on 3-6-09 @ 9:35 am.  On 3-16-09 @ 2 pm patient developed a mild headache.  Between 5:30 and 6 pm she developed general malaise, some little generalized aches.  Between 6 and 9 pm she developed joint aches, muscular aches, T 100 - 101 F, extreme nausea without vomiting and throughout the evening all the symptoms became worse.  After 9 pm she developed diarrhea, for which she took 2 OTC anti-diarrhea pills (? name) as directed for initial dose, without any relief.  She also experienced abdominal discomfort prior to and during diarrhea.  They offered no relief and she never took any more of this medication.  During the same night, her symptoms worsened throughout the evening, and could only sleep for 15 mins. at a time.  She experienced night sweats.  She took IBF 400 mg. PO @ 1 - 2 am on 3-19-09, also without relief, so did not take any further doses.  She then took Tylenol 1000  mg.  Q 4-6 hrs., but not more than 4 doses in 24 hrs. with some relief throughout the days that she had these symptoms.  On 3-18 PM or 3-19 PM, she began to take chewable pepto ismal for nausea, because it was so severe.  She also drank juice and water throughout the days of these symptoms.  The fever left either 3-20-09 in the evening or 3-21-09 @ 2 - 3 am, and then she was able to sleep.  All of these symptoms continued, but she was feeling progressively better.  She did not feel well enough to return to work until 3-23-09, but reports that she is not feeling well.  She reports feeling lethargic and joint aches continuing.  She complains especially of cervical neck pain with limited ROM, and has made an appointment with her neurosurgeon, since she had surgery last year.  She also complains of her shoulders and hands bothering her, where she has arthritis.  She has not taken her Voltran in 1 week, because she was taking other medication.  She will be talking with her PMD later today.